β2‐adrenoceptor agonists and antagonists and risk of Parkinson's disease

Abstract

Use of propranolol appears to be associated with an increased risk of PD, whereas use of β2-agonists is associated with a decreased risk of PD. © 2018 International Parkinson and Movement Disorder Society.